GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Pharmaceuticals market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Pharmaceuticals market reports here.

NEW Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • $3,495
  • June 2022
This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics.

NEW Electronic Health Records (EHRs) – Analyzing Trends, Technologies, Physicians’ Adoption and Perceptions, Use Barriers and Opportunities, and Future Prospects

  • $1,495
  • June 2022
EHRs have long been touted as a key element for achieving more efficient healthcare. One of the primary aims of EHRs was to improve data flow within healthcare systems, to...

NEW Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031

  • $3,995
  • June 2022
Colorectal cancer (CRC) (ICD-10 = C18–C20), also referred as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy originating from...

NEW Artificial Intelligence (AI) in Drug Discovery – Thematic Research

  • $1,950
  • June 2022
In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more...

NEW Age-Related Macular Degeneration Epidemiology Analysis and Forecast, 2021-2031

  • $3,995
  • June 2022
Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision....

NEW Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • $3,495
  • June 2022
This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics.

NEW Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • $3,495
  • June 2022
This reports provides a data-driven overview of the current and future competitive landscape in Interstitial Cystitis therapeutics.

NEW Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • $3,495
  • June 2022
This reports provides a data-driven overview of the current and future competitive landscape in Polymyositis and Dermatomyositis therapeutics.

NEW Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H1 2022

  • $495
  • June 2022
BioNTech/Pfizer’s Comirnaty, Moderna’s Spikevax, and Pfizer’s Paxlovid are the top three marketed drugs with the highest peak forecast sales. Comirnaty remains the leading prophylactic vaccine for COVID-19 with the highest...

NEW Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031

  • $3,995
  • June 2022
Osteoarthritis (OA) is a slowly progressive joint disease that is typically seen in middle-aged to elderly people. It is characterized by the breakdown of the cartilage, bony changes of the...